Cytokines in the Treatment of Human Disease: The Interferon System—from the Laboratory to the Clinic

[1]  S. Bohlander,et al.  Nomenclature of the Human Interferon Genesa , 1994 .

[2]  C. Samuel,et al.  The eIF-2 alpha protein kinases, regulators of translation in eukaryotes from yeasts to humans. , 1993, The Journal of biological chemistry.

[3]  S. B. Lee,et al.  The interferon-induced double-stranded RNA-activated human p68 protein kinase inhibits the replication of vaccinia virus. , 1993, Virology.

[4]  Robert H. Silverman,et al.  Expression cloning of 2-5A-dependent RNAase: A uniquely regulated mediator of interferon action , 1993, Cell.

[5]  H. Arnheiter,et al.  Switch in antiviral specificity of a GTPase upon translocation from the cytoplasm to the nucleus , 1993, Journal of virology.

[6]  R. Gentz,et al.  The human gamma interferon receptor accessory factor encoded by chromosome 21 transduces the signal for the induction of 2',5'-oligoadenylate-synthetase, resistance to virus cytopathic effect, and major histocompatibility complex class I antigens , 1993, Journal of virology.

[7]  G. Antonelli,et al.  2',5'-Oligoadenylate synthetase activity as a responsive marker during interferon therapy for chronic hepatitis C. , 1993, Journal of interferon research.

[8]  M. Katze,et al.  Constitutive expression of human double-stranded RNA-activated p68 kinase in murine cells mediates phosphorylation of eukaryotic initiation factor 2 and partial resistance to encephalomyocarditis virus growth , 1992, Journal of Virology.

[9]  M. Katze,et al.  Malignant transformation by a mutant of the IFN-inducible dsRNA-dependent protein kinase. , 1992, Science.

[10]  Y. Mitsui,et al.  Three‐dimensional crystal structure of recombinant murine interferon‐beta. , 1992, The EMBO journal.

[11]  M. David,et al.  Activation of transcription factors by interferon-alpha in a cell-free system. , 1992, Science.

[12]  J. Darnell,et al.  Interferon-dependent tyrosine phosphorylation of a latent cytoplasmic transcription factor. , 1992, Science.

[13]  P. Staeheli,et al.  Nuclear localization of mouse Mx1 protein is necessary for inhibition of influenza virus , 1992, Journal of virology.

[14]  M. Horisberger.  Interferon-induced human protein MxA is a GTPase which binds transiently to cellular proteins , 1992, Journal of virology.

[15]  Xin-Yuan Fu.  A transcription factor with SH2 and SH3 domains is directly activated by an interferon α-induced cytoplasmic protein tyrosine kinase(s) , 1992, Cell.

[16]  M. Fellous,et al.  A protein tyrosine kinase in the interferon α β signaling pathway , 1992, Cell.

[17]  A. Hovanessian,et al.  The 69-kDa 2-5A synthetase is composed of two homologous and adjacent functional domains. , 1992, The Journal of biological chemistry.

[18]  C. Samuel,et al.  Mechanism of interferon action: cDNA structure, expression, and regulation of the interferon-induced, RNA-dependent P1/eIF-2 alpha protein kinase from human cells. , 1992, Virology.

[19]  C. Samuel,et al.  Mechanism of interferon action: alpha and gamma interferons differentially affect mRNA levels of the catalytic subunit of protein kinase A and protein Mx in human cells , 1992, Journal of virology.

[20]  P. Staeheli,et al.  Mechanism of human MxA protein action: variants with changed antiviral properties. , 1992, The EMBO journal.

[21]  O. Haller,et al.  Human and mouse Mx proteins inhibit different steps of the influenza virus multiplication cycle , 1992, Journal of virology.

[22]  P. Lengyel,et al.  The interferon system. A bird's eye view of its biochemistry. , 1992, The Journal of biological chemistry.

[23]  G. Lutfalla,et al.  The structure of the human interferon alpha/beta receptor gene. , 1992, The Journal of biological chemistry.

[24]  A. Ishihama,et al.  Interferon-inducible mouse Mx1 protein that confers resistance to influenza virus is GTPase. , 1991, The Journal of biological chemistry.

[25]  N. Reich,et al.  Repression of the interferon signal transduction pathway by the adenovirus E1A oncogene. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[26]  M. Harter,et al.  Inhibition of interferon-inducible gene expression by adenovirus E1A proteins: block in transcriptional complex formation. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[27]  R. Kumar,et al.  Cloning, sequencing, and expression of two murine 2'-5'-oligoadenylate synthetases. Structure-function relationships. , 1991, The Journal of biological chemistry.

[28]  B. Williams,et al.  Transcriptional regulation of interferon-stimulated genes. , 1991, European journal of biochemistry.

[29]  A. Hovanessian.  Interferon-induced and double-stranded RNA-activated enzymes: a specific protein kinase and 2',5'-oligoadenylate synthetases. , 1991, Journal of interferon research.

[30]  C. Samuel,et al.  Antiviral actions of interferon. Interferon-regulated cellular proteins and their surprisingly selective antiviral activities. , 1991, Virology.

[31]  S E Ealick,et al.  Three-dimensional structure of recombinant human interferon-gamma. , 1991, Science.

[32]  H. Thomas,et al.  Expression of the terminal protein region of hepatitis B virus inhibits cellular responses to interferons alpha and gamma and double-stranded RNA. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[33]  E. Coccia,et al.  A full-length murine 2-5A synthetase cDNA transfected in NIH-3T3 cells impairs EMCV but not VSV replication. , 1990, Virology.

[34]  C. Jones,et al.  Expression and reconstitution of a biologically active human interferon-gamma receptor in hamster cells. , 1990, The Journal of biological chemistry.

[35]  G. Lutfalla,et al.  Genetic transfer of a functional human interferon α receptor into mouse cells: Cloning and expression of its c-DNA , 1990, Cell.

[36]  S. Banks,et al.  Recombinant interferon alfa therapy for chronic hepatitis C. A randomized, double-blind, placebo-controlled trial. , 1989, The New England journal of medicine.

[37]  M. Aebi,et al.  cDNA structures and regulation of two interferon-induced human Mx proteins , 1989, Molecular and cellular biology.

[38]  M. Rizzetto,et al.  Treatment of Chronic Type D (Delta) Hepatitis with Alpha Interferon , 1989, Seminars in liver disease.

[39]  M. Aguet,et al.  Molecular cloning and expression of the human interferon-γ receptor , 1988, Cell.

[40]  William E. Stewart,et al.  The Interferon System , 1979, Springer Vienna.

[41]  J. Lindenmann,et al.  Virus interference. I. The interferon , 1957, Proceedings of the Royal Society of London. Series B - Biological Sciences.

[42]  M. Katze,et al.  Tumor suppressor function of the interferon-induced double-stranded RNA-activated protein kinase. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[43]  R. Ransohoff,et al.  Interferon-induced antiviral actions and their regulation. , 1993, Advances in virus research.

[44]  S. Baron.  Interferon : principles and medical applications , 1992 .

[45]  M. Caron,et al.  Structure-Function Relationships , 1991 .

[46]  M. Gunst,et al.  Interferon-induced proteins: identification of Mx proteins in various mammalian species. , 1991, Virology.

[47]  P. Staeheli.  Interferon-induced proteins and the antiviral state. , 1990, Advances in virus research.

[48]  M. Aguet.  The interferon-gamma receptor: a comparison with other cytokine receptors. , 1990, Journal of interferon research.

[49]  H. Thomas,et al.  Antiviral therapy: hepatitis B. , 1990, British medical bulletin.

[50]  C. Samuel,et al.  Mechanisms of the antiviral action of interferons. , 1988, Progress in nucleic acid research and molecular biology.

[51]  K C Zoon,et al.  Interferons and their actions. , 1987, Annual review of biochemistry.

[52]  C. Weissmann,et al.  The interferon genes. , 1986, Progress in nucleic acid research and molecular biology.